Prof. Dr. Arsenal SEZGİN ALİKANOĞLU

1. Diagnostic value of cyclin D1 immunohistochemistry in differentiating malignant mesothelioma from reactive mesothelial proliferation

Nergiz D., SEZGİN ALİKANOĞLU A., SÜREN D.

Annals of Diagnostic Pathology , cilt.78, 2025 (SCI-Expanded, Scopus)

2. Detection of High-Risk Human Papillomavirus (HPV), p16 and EGFR in Lung Cancer: Insights from the Mediterranean Region of Turkey

SEZGİN ALİKANOĞLU A., Karaçay İ. A.

Viruses , cilt.16, sa.8, 2024 (SCI-Expanded, Scopus)

3. Claudin 1, 4 and 7 Expression in Malignant Melanoma

Nergiz D., SÜREN D., Yıldırım M., SEZGİN ALİKANOĞLU A., Sayiner A., Sezer C.

Indian Journal of Surgery , cilt.85, sa.5, ss.1218-1223, 2023 (SCI-Expanded, Scopus)

4. Leptin and leptin receptor expression in breast carcinomas and their relationship with clinicopathological features

Atalay Karacay I., SEZGİN ALİKANOĞLU A., SÜREN D., ÖZTÜRK B., KARAKAŞ B. R., Sezer C.

Human Pathology Reports , cilt.30, 2022 (Scopus)

5. Expression of p16 in pterygium and its relation with epithelial dysplasia and possible etiologic role of HPV

Süren E., Nergiz D., SÜREN D., SEZGİN ALİKANOĞLU A., TOSUN YILDIRIM H., Altun Z. A.

Indian Journal of Pathology and Microbiology , cilt.65, sa.2, ss.258-261, 2022 (SCI-Expanded, Scopus)

6. Concordance of HER2 status tested by IHC and FISH in biopsy and surgical resection specimens and comparison with clinicopathological features in gastric carcinoma

Nergiz D., SEZGİN ALİKANOĞLU A., SÜREN D., Gömceli I., ÖZTÜRK B.

Indian Journal of Pathology and Microbiology , cilt.65, sa.2, ss.321-327, 2022 (SCI-Expanded, Scopus)

7. Rate of Incidental Pathological Lesions ın Reduction Mammoplasty Specimens and Incidence of Invasive Breast Carcinoma Following Breast Reduction Operation

Nergiz D., SÜREN D., SEZGİN ALİKANOĞLU A., TOSUN YILDIRIM H., Altun Z. A., Uslu A.

Aesthetic Plastic Surgery , cilt.46, sa.1, ss.83-90, 2022 (SCI-Expanded, Scopus)

8. The role of Helicobacter pylori and gastroesophageal reflux disease in otitis media with effusion and evaluation of MUC4, MUC5B mucin genes and inflammatory cytokines in guinea pig middle ears

Eren E., Yılmaz M. D., ÇEKİN Y., SEZGİN ALİKANOĞLU A., EYİGÖR H., Yılmaz G. Ö., et al.

Turkish Journal of Ear Nose and Throat , cilt.30, sa.4, ss.131-139, 2020 (Scopus, TRDizin)

9. HMGB1 expression in urothelial carcinoma of the bladder

SÜREN D., TOSUN YILDIRIM H., Atalay I., Sayiner A., Yildirim M., SEZGİN ALİKANOĞLU A., et al.

Journal of B.U.ON. , cilt.23, sa.6, ss.1882-1886, 2018 (SCI-Expanded, Scopus)

10. Expression of claudin 1, 4 and 7 in thyroid neoplasms

SÜREN D., Yildirim M., Sayiner A., SEZGİN ALİKANOĞLU A., Atalay İ., Gündüz U. R., et al.

Oncology Letters , cilt.13, sa.5, ss.3722-3726, 2017 (SCI-Expanded, Scopus)

11. Expression of COX-2 and Bcl-2 in Paget's disease of the breast

SEZGİN ALİKANOĞLU A., Yildirim M., SÜREN D., Tutus B., KAYA V., Topal C. S., et al.

Asian Pacific Journal of Cancer Prevention , cilt.16, sa.3, ss.1041-1045, 2015 (Scopus)

12. Pelvic Actinomycosis; the disease for which diagnostic and therapeutic delay is still being experienced Pelvik actinomycosis; Tanısal ve tedavisel gecikmenin halen yaşandığı hastalık

SÜREN D., Yıldırım M., SEZGİN ALİKANOĞLU A., Gökay A. A., Sezer C.

Journal of Clinical and Analytical Medicine , cilt.6, sa.5, ss.653-655, 2015 (Scopus, TRDizin)

13. Expression pattern and prognostic significance of claudin 1, 4 and 7 in pancreatic cancer

SEZGİN ALİKANOĞLU A., Gunduz S., Demirpence O., SÜREN D., Gunduz U. R., Sezer C., et al.

Asian Pacific Journal of Cancer Prevention , cilt.16, sa.10, ss.4387-4392, 2015 (Scopus)

14. Loss of tight junction proteins (Claudin 1, 4,and 7) correlates with aggressive behavior in colorectal carcinoma

SÜREN D., Yildirim M., KAYA V., SEZGİN ALİKANOĞLU A., Bülbüller N., YILDIZ M., et al.

Medical Science Monitor , cilt.20, ss.1255-1262, 2014 (SCI-Expanded, Scopus)

15. Prognostic role of Aurora-A expression in metastatic colorectal cancer patients

Goktas S., Yildirim M., SÜREN D., SEZGİN ALİKANOĞLU A., Dilli U. D., Bulbuller N., et al.

Journal of B.U.ON. , cilt.19, sa.3, ss.686-691, 2014 (SCI-Expanded, Scopus)

16. The role of High Mobility Group Box 1 (HMGB1) in colorectal cancer

SÜREN D., Yildirim M., Demirpençe Ö., KAYA V., SEZGİN ALİKANOĞLU A., Bülbüller N., et al.

Medical Science Monitor , cilt.20, ss.530-537, 2014 (SCI-Expanded, Scopus)

17. Lack of any prognostic role of insulin-like growth factor-1 receptor in non-small cell lung cancer

Dilli U. D., Yildirim M., SÜREN D., SEZGİN ALİKANOĞLU A., KAYA V., Goktas S., et al.

Asian Pacific Journal of Cancer Prevention , cilt.15, sa.14, ss.5753-5757, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. Lack of relation of AKAP12 with p53 and Bcl-2 in colorectal carcinoma

SÜREN D., Yildirim M., SEZGİN ALİKANOĞLU A., KAYA V., YILDIZ M., Dilli U. D., et al.

Asian Pacific Journal of Cancer Prevention , cilt.15, sa.8, ss.3415-3418, 2014 (SCI-Expanded, Scopus)

19. Expression of cyclooxygenase-2 and Bcl-2 in breast cancer and their relationship with triple-negative disease

SEZGİN ALİKANOĞLU A., Yildirim M., SÜREN D., YILDIZ M., KAYA V., Dilli U. D., et al.

Journal of B.U.ON. , cilt.19, sa.2, ss.430-434, 2014 (SCI-Expanded, Scopus)

20. Prognostic importance of Bcl-2 expression in colon cancer Kolon kanserinde Bcl-2 ekspresyonunun prognostik önemi

SEZGİN ALİKANOĞLU A., Yildirim M., SÜREN D., Kargi A., YILDIZ M., Sezer C., et al.

Journal of Clinical and Analytical Medicine , cilt.4, sa.5, ss.404-407, 2013 (Scopus, TRDizin)

21. HER 2 expression in gastric cancer Mide kanserinde HER 2 ekspresyonu

SEZGİN ALİKANOĞLU A., Yildirim M., SÜREN D., YILDIZ M., Sezer C., Göktaş S., et al.

Journal of Clinical and Analytical Medicine , cilt.4, sa.4, 2013 (Scopus, TRDizin)

22. Prognostic significance of lymphovascular and perivascular invasion in colon cancer Lenfovasküler ve perivasküler i̇nvazyonun kolon kanserinde prognostik önemi

SÜREN D., Yildirim M., Elal R., YILDIZ M., Sezer C., Bülbüller N., et al.

Journal of Clinical and Analytical Medicine , cilt.4, sa.4, 2013 (Scopus, TRDizin)

23. Tumour markers in peritoneal washing fluid - contribution to cytology

Yıldırım M., SÜREN D., YILDIZ M., SEZGİN ALİKANOĞLU A., Kaya V., Doluoglu S. G., et al.

Asian Pacific journal of cancer prevention : APJCP , cilt.14, sa.2, ss.1027-1030, 2013 (Scopus)

24. Bcl-2 and Ki-67 expression in young women with breast cancer Genç Yaş Meme Kanserli Kadın Hastalarda Bcl-2 ve Ki-67 Ekspresyonu

SEZGİN ALİKANOĞLU A., Yildirim M., SÜREN D., Kargi A., YILDIZ M., Sezer C., et al.

Journal of Clinical and Analytical Medicine , cilt.4, sa.5, ss.386-389, 2013 (Scopus, TRDizin)

25. A clinicopathological evaluation of male patients with breast cancer

İLHAN E., Bati B., ALEMDAR A., COŞKUN A. K., SEZGİN ALİKANOĞLU A., Yildirim M., et al.

Breast Care , cilt.4, sa.5, ss.308-314, 2009 (SCI-Expanded, Scopus)

26. Diagnostic difficulties in peripancreatic tuberculous lymphadenitis: A case report

İLHAN E., Erkan N., YILDIRIM M., Polat A. F., Çirak K., SEZGİN ALİKANOĞLU A.

Turkish Journal of Gastroenterology , cilt.17, sa.2, ss.137-139, 2006 (Scopus, TRDizin)

Prof. Dr. Arsenal SEZGİN ALİKANOĞLU

Yayınlar & Eserler